Skip to main content

Advertisement

Table 4 The effects of Hsp expression on response to CRT

From: Prognostic role of HPV infection in esophageal squamous cell carcinoma

Molecular Marker Clinical Downstaging (n = 74) p value
Responder Non-Responder
Hsp 16.2 low intensity 29 (82.9%) 6 (17.1%) p < 0.01
high intensity 9 (23.1%) 30 (76.9%)
Hsp 27 low intensity 22 (61.1%) 14 (38.9%) p = 0.102
high intensity 16 (42.1%) 22 (57.9%)
Hsp 90 low intensity 21 (84.0%) 4 (16.0%) p < 0.001
high intensity 17 (34.7%) 32 (65.3%)